BIOTECHQUITY Trademark

Trademark Overview


On Monday, April 8, 2024, a trademark application was filed for BIOTECHQUITY with the United States Patent and Trademark Office. The USPTO has given the BIOTECHQUITY trademark a serial number of 98489553. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, October 29, 2024. The BIOTECHQUITY trademark is filed in the Advertising, Business and Retail Services category with the following description:

Market research and business marketing consulting services for life sciences companies, organizations, and institutions; Providing business and biostatistical business information and business data analysis services for life sciences companies, organizations, and institutions; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of life sciences companies to assist them with clinical research, clinical trials, and applications for drug approval; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Business consulting and business management services for life sciences companies, organizations, and institutions in the fields of health economics, outcomes research, epidemiological studies, payer research, and market access; Promoting public and government awareness of and interest ...

General Information


Serial Number98489553
Word MarkBIOTECHQUITY
Filing DateMonday, April 8, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2025

Trademark Statements


Pseudo MarkBIO TECH EQUITY
Goods and ServicesMarket research and business marketing consulting services for life sciences companies, organizations, and institutions; Providing business and biostatistical business information and business data analysis services for life sciences companies, organizations, and institutions; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of life sciences companies to assist them with clinical research, clinical trials, and applications for drug approval; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Business consulting and business management services for life sciences companies, organizations, and institutions in the fields of health economics, outcomes research, epidemiological studies, payer research, and market access; Promoting public and government awareness of and interest in issues relating to acceleration of medical solutions; promotion of public policies to accelerate development and adoption of new drugs and therapies; conducting post market research studies

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, April 8, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressWashington, DC 20015

Trademark Events


Event DateEvent Description
Monday, April 8, 2024NEW APPLICATION ENTERED
Monday, September 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 22, 2024ASSIGNED TO EXAMINER
Wednesday, October 23, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, October 23, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, October 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 23, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 8, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED